These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16640338)

  • 21. Iron chelation promoted by desazadesferrithiocin analogs: An enantioselective barrier.
    Bergeron RJ; Wiegand J; Weimar WR; McManis JS; Smith RE; Abboud KA
    Chirality; 2003 Aug; 15(7):593-9. PubMed ID: 12840823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The desferrithiocin (DFT) class of iron chelators: potential as antineoplastic agents.
    Kicic A; Chua AC; Baker E
    Anticancer Drug Des; 2001; 16(4-5):195-207. PubMed ID: 12049478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conjugates of desferrioxamine B (DFOB) with derivatives of adamantane or with orally available chelators as potential agents for treating iron overload.
    Liu J; Obando D; Schipanski LG; Groebler LK; Witting PK; Kalinowski DS; Richardson DR; Codd R
    J Med Chem; 2010 Feb; 53(3):1370-82. PubMed ID: 20041672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deferitazole, a new orally active iron chelator.
    Hider RC; Kong X; Abbate V; Harland R; Conlon K; Luker T
    Dalton Trans; 2015 Mar; 44(11):5197-204. PubMed ID: 25687725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in iron overload therapies. prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NA11 and their combinations.
    Kontoghiorghes GJ; Eracleous E; Economides C; Kolnagou A
    Curr Med Chem; 2005; 12(23):2663-81. PubMed ID: 16305464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological activity of novel calcium channel blockers: 2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acid esters and 2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters.
    Atwal KS; Bergey JL; Hedberg A; Moreland S
    J Med Chem; 1987 Apr; 30(4):635-40. PubMed ID: 2435903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of carboxylic acids, esters, alcohols and ethers containing a tetrahydropyran ring derived from 6-methyl-5-hepten-2-one.
    Hanzawa Y; Hashimoto K; Kasashima Y; Takahashi Y; Mino T; Sakamoto M; Fujita T
    J Oleo Sci; 2012; 61(11):631-40. PubMed ID: 23138252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of tridentate iron chelators: from desferrithiocin to ICL670.
    Nick H; Acklin P; Lattmann R; Buehlmayer P; Hauffe S; Schupp J; Alberti D
    Curr Med Chem; 2003 Jun; 10(12):1065-76. PubMed ID: 12678677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of iron chelator efficacy in iron-overloaded beagle dogs and monkeys (Cebus apella).
    Bergeron RJ; Wiegand J; Weimar WR; Lindstrom TC; Fannin TL; Ratliff-Thompson K
    Comp Med; 2004 Dec; 54(6):664-72. PubMed ID: 15679265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey model.
    Bergeron RJ; Streiff RR; Creary EA; Daniels RD; King W; Luchetta G; Wiegand J; Moerker T; Peter HH
    Blood; 1993 Apr; 81(8):2166-73. PubMed ID: 8471775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical and biological characterization of technetium(I) and Rhenium(I) tricarbonyl complexes with dithioether ligands serving as linkers for coupling the Tc(CO)(3) and Re(CO)(3) moieties to biologically active molecules.
    Pietzsch HJ; Gupta A; Reisgys M; Drews A; Seifert S; Syhre R; Spies H; Alberto R; Abram U; Schubiger PA; Johannsen B
    Bioconjug Chem; 2000; 11(3):414-24. PubMed ID: 10821659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron chelators and iron toxicity.
    Brittenham GM
    Alcohol; 2003 Jun; 30(2):151-8. PubMed ID: 12957300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of hydroxamate-based iron chelators.
    Bergeron RJ; Wiegand J; McManis JS; Perumal PT
    J Med Chem; 1991 Nov; 34(11):3182-7. PubMed ID: 1956036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural alterations in desferrioxamine compatible with iron clearance in animals.
    Bergeron RJ; Liu ZR; McManis JS; Wiegand J
    J Med Chem; 1992 Dec; 35(25):4739-44. PubMed ID: 1469701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers.
    Kontoghiorghes GJ
    Hemoglobin; 2006; 30(2):329-47. PubMed ID: 16798657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative evaluation of iron clearance models.
    Bergeron RJ; Streiff RR; Wiegand J; Vinson JR; Luchetta G; Evans KM; Peter H; Jenny HB
    Ann N Y Acad Sci; 1990; 612():378-93. PubMed ID: 2127168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological properties of iron chelators based on a bis-2-(2-hydroxy-phenyl)-thiazole-4-carboxamide or -thiocarboxamide (BHPTC) scaffold.
    Rodriguez-Lucena D; Gaboriau F; Rivault F; Schalk IJ; Lescoat G; Mislin GL
    Bioorg Med Chem; 2010 Jan; 18(2):689-95. PubMed ID: 20036563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The origin of the differences in (R)- and (S)-desmethyldesferrithiocin. Iron-clearing properties.
    Bergeron RJ; Wiegand J; Ratliff-Thompson K; Weimar WR
    Ann N Y Acad Sci; 1998 Jun; 850():202-16. PubMed ID: 9668541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug evaluation: Deferitrin for iron overload disorders.
    Barton JC
    IDrugs; 2007 Jul; 10(7):480-90. PubMed ID: 17642018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chelation and mobilization of cellular iron by different classes of chelators.
    Zanninelli G; Glickstein H; Breuer W; Milgram P; Brissot P; Hider RC; Konijn AM; Libman J; Shanzer A; Cabantchik ZI
    Mol Pharmacol; 1997 May; 51(5):842-52. PubMed ID: 9145923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.